The man who led Gilead’s autoimmune pivot heads to Boston; Novartis gets a new chief for its AI Innovation Center
The hospital’s gone now but across the street from it, there used to be a clinic, a beat-up thing with peeling paint that, in a …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
